In their interest then to sell off and get down to 90% of 0.1c It requires actual substance for buyers to take control and price this as a successful enterprise. Bring back K2u to the front line No chance . It’s razzle dazzle to the end.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025